What is Ranomics?
Ranomics is a specialized provider of cell and protein engineering services, catering to the dynamic life sciences and biotechnology industries. Their core competency lies in developing innovative solutions that accelerate research and development for their partners. By focusing on custom DNA variant libraries and high-throughput screening, Ranomics has a proven track record, having supported over 100 projects for prominent biotechnology firms and research institutions. The company's Ph.D.-level scientific team offers deep expertise, enabling clients to achieve critical breakthroughs in biologic development and drug discovery.
How much funding has Ranomics raised?
Ranomics has raised a total of $2.8M across 2 funding rounds:
Angel/Seed
$1.2M
Angel/Seed
$1.6M
Angel/Seed (2016): $1.2M, investors not publicly disclosed
Angel/Seed (2016): $1.6M, investors not publicly disclosed
What's next for Ranomics?
The recent major strategic investment positions Ranomics for accelerated growth and enhanced service delivery. This capital infusion is expected to fuel further innovation in their cell and protein engineering platforms, potentially expanding their service offerings and client base. The company's focus on empowering partners with speed and precision in R&D suggests a strategic intent to solidify its position as a key enabler of scientific advancement in the biotechnology ecosystem. Future developments may include strategic partnerships or the expansion of their proprietary technologies.
See full Ranomics company page
